Prudential Financial
TVTX icon

Prudential Financial’s Travere Therapeutics TVTX Stock Holding History

Prudential Financial’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.82M Sell
162,235
-57,510
-26% -$1.72M 0.01% 932
2025
Q4 		$8.4M Buy
219,745
+82,134
+60% +$2.67M 0.01% 691
2025
Q3 		$3.29M Sell
137,611
-106,645
-44% -$2M ﹤0.01% 1131
2025
Q2 		$3.61M Buy
244,256
+615
+0.3% +$10.2K ﹤0.01% 1092
2025
Q1 		$4.37M Sell
243,641
-725,500
-75% -$14.7M 0.01% 898
2024
Q4 		$16.9M Buy
969,141
+365,200
+60% +$6.46M 0.02% 434
2024
Q3 		$8.45M Buy
603,941
+168,300
+39% +$1.75M 0.01% 748
2024
Q2 		$3.58M Buy
435,641
+370,380
+568% +$2.49M 0.01% 1072
2024
Q1 		$503K Sell
65,261
-23,800
-27% -$201K ﹤0.01% 2171
2023
Q4 		$801K Buy
+89,061
New +$648K ﹤0.01% 1934
2022
Q4 		– Sell
-14,045
Closed -$346K – 2703
2022
Q3 		$346K Buy
+14,045
New +$363K ﹤0.01% 2248
2021
Q3 		– Sell
-84,064
Closed -$1.23M – 2627
2021
Q2 		$1.23M Sell
84,064
-95,038
-53% -$1.87M ﹤0.01% 1733
2021
Q1 		$4.47M Sell
179,102
-162,180
-48% -$4.48M 0.01% 1074
2020
Q4 		$9.3M Sell
341,282
-103,341
-23% -$2.41M 0.02% 769
2020
Q3 		$8.21M Sell
444,623
-79,583
-15% -$1.55M 0.02% 743
2020
Q2 		$10.7M Sell
524,206
-6,508
-1% -$104K 0.02% 671
2020
Q1 		$7.74M Sell
530,714
-88,610
-14% -$1.33M 0.02% 742
2019
Q4 		$8.79M Buy
619,324
+112,051
+22% +$1.43M 0.01% 907
2019
Q3 		$5.88M Buy
507,273
+254,174
+100% +$4.2M 0.01% 1041
2019
Q2 		$5.08M Buy
253,099
+1,010
+0.4% +$19.9K 0.01% 1149
2019
Q1 		$5.71M Buy
252,089
+2,223
+0.9% +$49.1K 0.01% 1085
2018
Q4 		$5.65M Sell
249,866
-82,650
-25% -$2.06M 0.01% 1046
2018
Q3 		$9.55M Sell
332,516
-38,427
-10% -$1.1M 0.01% 933
2018
Q2 		$10.1M Buy
370,943
+155,520
+72% +$4.14M 0.02% 916
2018
Q1 		$4.82M Sell
215,423
-11,680
-5% -$278K 0.01% 1188
2017
Q4 		$4.79M Buy
227,103
+32,963
+17% +$753K 0.01% 1180
2017
Q3 		$4.83M Buy
194,140
+154,170
+386% +$3.39M 0.01% 1167
2017
Q2 		$775K Buy
+39,970
New +$725K ﹤0.01% 1923

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial's TVTX Position: Q1 2026 in Review

Prudential Financial reduced its Travere Therapeutics (TVTX) stake by 26% in Q1 2026, selling an estimated $1.72M and leaving 162,235 shares worth $4.82M. The position accounts for 0.01% of the portfolio, ranked #932.

Prudential Financial first reported a position in TVTX in Q2 2017 and has held it in 28 quarters since. The position peaked at $16.9M in Q4 2024. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Prudential Financial held 162,235 shares of Travere Therapeutics worth $4.82M as of Q1 2026.
  • Prudential Financial sold 57,510 Travere Therapeutics shares in Q1 2026, an estimated $1.72M.
  • Travere Therapeutics made up 0.01% of Prudential Financial's portfolio in Q1 2026, its #932 holding.
  • Prudential Financial first reported a position in Travere Therapeutics in Q2 2017 and has held it in 28 quarters since.
  • Prudential Financial's Travere Therapeutics position peaked at $16.9M in Q4 2024.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.